Menu
Recruiting NCT06458985

Disclosure Intervention for People in Treatment for Opioid Use Disorder

No phase Interventional Opioid Use Disorder

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Disclosing Recovery: A Decision Aid and Toolkit.
Who it may be relevant to
Registry conditions: Opioid Use Disorder. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Disclosure Intervention to Reduce Social Isolation and Facilitate Recovery Among People in Treatment for Opioid Use Disorder

Overview

The goal of this clinical trial is to test a disclosure intervention among people in treatment for opioid use disorder. The main question it aims to answer is whether people who receive a disclosure intervention have better treatment- and recovery-related outcomes one year after receiving the intervention. Participants will complete a brief disclosure intervention designed to help them (1) make key disclosures related to disclosure and (2) build skills to disclose. Researchers will compare results to participants in a waitlist comparator condition, who receive the intervention at the end of the study.

Interventions

  • Behavioral Disclosing Recovery: A Decision Aid and Toolkit
    The Disclosing Recovery intervention is designed to help people in treatment for opioid use disorder (1) make key decisions regarding disclosure, including whether, why, what, how, and when to disclose, and (2) build skills to disclose, including planning what to say, practicing disclosure, and preparing for negative responses.

Primary outcome measures

  • Retention in treatment [Time frame: 1 year]
  • Illicit opioid use [Time frame: 1 year]
Secondary outcome measures (2)
  • Recovery capital score [Time frame: 1 year]
  • Quality of life score [Time frame: 1 year]

Eligibility criteria

Inclusion criteria

  • Client of Brandywine Counseling \& Community Services
  • Receiving opioid use disorder treatment at Brandywine Counseling \& Community Services
  • Considering disclosing one's opioid use disorder history and/or treatment to someone new

Exclusion criteria

  • Diagnosis of schizophrenia
  • Participation in pilot study of intervention

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • Brandywine Counseling & Community Services — Wilmington

Identifiers

NCT: NCT06458985 · UDISCLOSE RCT · R01DA059557

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗